| Metric | Value (₹ Cr) | vs Q4 FY25 |
|---|---|---|
| Revenue | 740.10 | 2.2% |
| Total Income | 743.21 | 2.2% |
| Expenditure | 548.33 | 0.2% |
| PBT | 194.88 | 8.2% |
| Net Profit | 151.54 | 2.5% |
| OPM | 32.12% | 0.88pp |
| NPM | 20.39% | 0.07pp |
| EPS | 9.07 | 2.1% |
IKS Health Reports 16% YoY Revenue Growth and 59% PAT Increase in Q1 FY26 2025
31 Jul 2025 · 31 Jul 2025, 10:21 pm
Summary
Inventurus Knowledge Solutions Ltd, a technology-enabled healthcare solutions provider, reported strong growth in Q1 FY26. IKS Health, a care enablement platform, reported a 16% YoY revenue growth in INR and 13% YoY in USD. The EBITDA was up 36% YoY and 5% QoQ, while PAT was up 59% YoY and 3% QoQ. The company's focus remains on deepening client value, investing in innovation, and scaling its platform to address the evolving needs of the healthcare ecosystem.
Key Highlights
- 1
16% YoY revenue growth in INR and 13% YoY in USD
- 2
Q1 EBITDA up 36% YoY and 5% QoQ
- 3
PAT up 59% YoY and 3% QoQ
- 4
EBITDA margin improvement to 32%
- 5
Strategic partnerships with Mission Community Hospital, Bicycle Health, OrthoNy, and Atop 5 Health System
- 6
Received several notable recognitions including ET HRWorld Exceptional Employee Experience Award, BWCFO Finance & Strategy Excellence Awards, and Excellence in Mergers and Acquisitions Award
Management Comments
Sachin K. Gupta
Founder & Global CEO, IKS Health
Our performance this quarter reflects the continued momentum in our business and the stickiness of our integrated tech-led care enablement platform built on strong client relationships, scalable solutions, and disciplined execution. The sustained revenue growth at 16% and improvement of EBITDA margin for the combined entity to 32% demonstrates the impact of our technology-led care enablement platform and global delivery capabilities.
Nithya Balasubramanian
CFO, IKS Health
We delivered a strong financial performance in Q1 FY26, driven by consistent revenue growth and continued focus on operational efficiency. Our EBITDA margin improvement reflects disciplined cost management, scalability of our platform, and prudent capital allocation. As we move ahead, we remain committed to sustaining healthy margins while strategically investing in capabilities that drive long-term value creation.
Informational and educational content only. Not investment advice.